Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma

British Journal of Cancer

Volumn 74, Issue 8, 1996, Pages 1253-1257

  Maurizi, M ^a   Almadori, G ^a   Ferrandina, G ^a   Distefano, M ^a   Romanini, M E ^a   Cadoni, G ^a   Benedetti Panici, P ^a   Paludetti, G ^a   Scambia, G ^a   Mancuso, S ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Epidermal growth factor receptor; Larynx; Prognosis; Squamous cell carcinoma

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTPATIENT; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; SQUAMOUS CELL; SQUAMOUS CELL CARCINOMA;

EID: 10244243722     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.525     Document Type: Article

References (32)

1. ANDERSON JA, IRISH JC AND NGAN BY. (1992). Prevalence of RAS oncogene mutation in head and neck carcinomas. J. Otolaryngol., 21, 321-326.
2. BRADFORD MM. (1976). A rapid and sensitive method for quantitation of microgram quantities of protein using the principle of protein dye-binding. Anal. Biochem., 72, 248-254.
3. BRENNAN JA, MAO L., HRUBAN RH, BOYLE JO, EBY YJ, KOCH WM, GOODMAN SN AND SIDRANSKY D. (1995). Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N. Engl. J. Med., 332, 429-435.
4. COLTRERA MD. (1993). The use of cell proliferation markers in tissue sections as indicators of prognosis. In Head and Neck Cancer, Vol. III, Johnson JT and Didolkar MS. (eds). pp. 379-384. Elsevier Science Publishers: Amsterdam.
5. COX DR. (1972). Regression models and life tables. J. R. Stat. Soc., 34, 197-220.
6. DASSONVILLE O. FORMENTO JL, FRANCOUAL M, RAMAIOLI A. SANTINI J, SCHNEIDER M, DEMARD F AND MILANO G. (1993). Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer. J. Clin. Oncol., 11, 1873-1878.
7. FRY DW, KRAKER AJ, MCMICHAEL A, AMBROSO LA. NELSON JM, LEOPOLD WR, CONNORS RW AND BRIDGES AJ. (1994). A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. Science. 265, 1093-1095.
8. GRANDIS JR AND TWEARDY DY. (1993). Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res., 53, 3579-3584.
9. HERMANEK P AND SOBIN LH. (1992). Larynx In International Union against Cancer. TNM Classification of Malignant Tumors, Edn 4, pp. 25-28. Springer-Verlag: Berlin.
10. IACOBELLI S, NATOLI C, POLIZZI G et al. (1987). A procedure for the simultaneous assay of estrogen, progesterone and epidermal growth factor receptors in the same tissue specimen. Proceedings of the course 'Biology and Biochemistry of Normal and Cancer Cell Growth' Harwood Acad. Publish., 5, 195-202, ERICE, 23 31 March.
11. IRISH JC AND BERNSTEIN A. (1993). Oncogenes in head and neck cancer. Laryngoscope, 103, 42-52.
12. KAPLAN E AND MEIER P. (1958). Nonparametric estimation from incomplete observation. J. Am. Stat. Assoc., 53, 457-481.
13. KEARSELEY JH, BRYSON G, BATTISTUTTA D AND COLLINS RJ. (1991). Prognostic importance of cellular DNA content in head-and-neck squamous-cell cancers. A comparison of retrospective and prospective series. Int. J. Cancer, 47, 31-37.
14. KURACHI H, MORESHIGE K, AMEMIYA K, ADACHI H, HIROTA K, MIYAKE A AND TANIZAWA O. (1991). Importance of transforming growth factor a/epidermal growth factor receptor autocrine growth mechanisms in an ovarian cancer cell line in vivo. Cancer Res., 51, 5956-5959.
15. MANTEL N. (1996). Evaluation of survival data and two new rank order statistics arising from its consideration. Cancer Chemother. Rep., 50, 163-170.
16. MAURIZI M, SCAMBIA G, BENEDETTI PANICI P, FERANDINA G, ALMADORI G, PALUDETTI G, DE VINCENZO R, DISTEFANO M, BRINCHI D, CADONI G AND MANCUSO S. (1992). EGF receptor expression in primary laryngeal cancer: correlation with clinicopathological features and prognostic significance. Int. J. Cancer, 52, 862-866.
17. MIYAGUCHI M, OLOFSSON J AND HELLQUIST HB. (1990). Expression of epidermal growth factor receptor in laryngeal dysplasia and carcinoma. Acta Otolaryngol., 110, 309-313.
18. MORESHIGE K, KURACHI H, AMEMIYA K, ADACHI H, INOUE M, MIYAKE A, TANIZAWA O AND SKOYAMA Y. (1991). Involvement of transforming growth factor a/epidermal growth factor receptor autocrine growth mechanism in an ovarian cancer cell line in vitro. Cancer Res., 51, 5951-5955.
19. NEAL DE, MARSH C AND BENNETT MK. (1991). Epidermal growth factor receptors in human bladder cancer: comparison of invasive and superficial tumors. Lancet, I, 366-368.
20. OZAWA S, UEDA M, ANDO N, SHIMIZU N AND ABE O. (1989). Prognostic significance of epidermal growth factor receptors in esophageal squamous-cell carcinomas. Cancer, 63, 2169-2173.
21. RUÀ S, COMINO A, FRUTTERO A, CERA G, SEMERIA C, LANZILLOTTA L AND BOFFETTA P. (1991). Relationship between histologic features, DNA flow cytometry, and clinical behavior of squamous cell carcinoma of the larynx. Cancer, 67, 141-149.
22. SAINSBURY JRC, FARNDON JR, NEEDHAM JK, MALCOLM AJ AND HARRIS AL. (1987). Epidermal growth factor receptor status as predictor of early recurrence or of death from breast cancer. Lancet, I, 1398-1401.
23. SANTINI J, FORMENTO JL, FRANCOUAI M, MILANO G, SCHNEIDER M, DASSONVILIE O AND DEMARD F. (1991). Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carinomas. Head and Neck, 13, 132-139.
24. SCAMBIA G, BENEDETTI PANICI P, BATTAGLIA F, FERRANDINA G, ALMADORI G, PALUDETTI G, MAURIZI M AND MANCUSO S. (1991). Receptors for epidermal growth factor and steroid hormones in primary laryngeal tumors. Cancer, 67, 1347 - 1351.
25. SCAMBIA G, BENEDETTI PANICI P, BATTAGLIA F, FERRANDINA G, BAIOCCHI G, GREGGI S, DE VINCENZO R AND MANCUSO S, (1992). Significance of epidermal growth factor receptor in advanced ovarian cancer. J. Clin. Oncol., 10, 529 - 535.
26. SCAMBIA G, CATOZZI L, BENEDETTI PANICI P, FERRANDINA G, ALMADORI G, PALUDETTI G, CADONI G, DISTEFANO M, PIFFANELLI A, MANCUSO S AND MAURIZI M, (1994a). Expression of ras oncogene p21 protein in normal and neoplastic laryngeal tissues: correlation with histopathological features and epidermal growth factor receptors. Br. J. Cancer, 69, 995 - 999.
27. SCAMBIA G, BENEDETTI PANICI P, FERRANDINA G, BATTAGLIA F, DISTEFANO M, D'ANDREA G, DE VINCENZO R, MANESCHI F, RANELLETTI FO AND MANCUSO S. (1994b). Significance of epidermal growth factor receptor expression in primary human endometrial cancer. Int. J. Cancer, 56, 26 - 30.
28. SCHNURCH HG, STEGMULLER M, VERING A, BECKMANN MW AND BENDER HG. (1994). Growth inhibition of xenotransplanted human carcinomas by a monoclonal antibody directed against the epidermal growth factor receptor. Eur. J. Cancer, 30, 491 - 496.
29. SILVERBERG E, BORING CC AND SQUIRES TS. (1990). Cancer Statistics CA. Cancer J. Clin., 40, 9 - 26.
30. SNOW GB. (1989). Evaluation and staging of the patient with head and neck cancer. In Cancer of the Head and Neck, 2nd ed. Myers EN and Suen JY. (eds). pp. 17 - 38. Churchill Livingstone: New York.
31. STANTON P, RICHARDS S, REEVES J, NIKOLIC M, EDINGTON K, CLARK L, ROBERTSON G, SOUTER D, MITCHELL R, HENDLER FJ, COOKE T, PARKINSON EK AND OZANNE BW. (1994). Epidermal growth factor receptor expression by human squamous cell carcinomas of the head and neck, cell lines and xenografts. Br. J. Cancer, 70, 427 - 433.
32. VELU TJ. (1990). Structure, function and transforming potential of the epidermal growth factor receptor. Mol. Cell. Endocrinol., 70, 205-216.